| Over a week ago | ||||
Berenberg analyst Anna… Berenberg analyst Anna Patrice raised the firm's price target on Elis to EUR 22 from EUR 21 and keeps a Buy rating on the shares. | ||||
JPMorgan analyst Sylvia… JPMorgan analyst Sylvia Barker raised the firm's price target on Elis to EUR 19 from EUR 16.50 and keeps an Overweight rating on the shares. | ||||
| Over a month ago | ||||
Morgan Stanley analyst… Morgan Stanley analyst Annelies Vermeulen raised the firm's price target on Elis to EUR 19.20 from EUR 18.80 and keeps an Overweight rating on the shares. | ||||
Berenberg analyst Anna… Berenberg analyst Anna Patrice raised the firm's price target on Elis to EUR 21 from EUR 20 and keeps a Buy rating on the shares. | ||||
| Over a quarter ago | ||||
JPMorgan analyst Sylvia… JPMorgan analyst Sylvia Barker upgraded Elis to Overweight from Neutral with an unchanged price target of EUR 16.50. The analyst says the company offers "relatively defensive" volumes in a downturn scenario and notes that its pricing has surprised on the upside. | ||||
JPMorgan analyst Sylvia… JPMorgan analyst Sylvia Barker downgraded Elis to Neutral from Overweight with a EUR 17 price target. | ||||
Bryan Garnier analyst… Bryan Garnier analyst Bruno De La Rochebrochard initiated coverage of Elis with a Buy rating and EUR 23 price target. The company is positioned to benefit from higher hygiene standards post COVID, De La Rochebrochard tells investors in a research note. | ||||
Morgan Stanley analyst… Morgan Stanley analyst Annelies Vermeulen lowered the firm's price target on Elis to EUR 18.80 from EUR 21 and keeps an Overweight rating on the shares. | ||||
Societe Generale analyst… Societe Generale analyst Sabrina Blanc lowered the firm's price target on Elis to EUR 18.30 from EUR 18.60 and keeps a Buy rating on the shares. | ||||
JPMorgan analyst Sylvia… JPMorgan analyst Sylvia Barker upgraded Elis to Overweight from Neutral with an unchanged price target of EUR 17. The company currently screens well within the group, trading on valuation multiples toward the bottom of the range for the sector, Barker tells investors in a research note. The analyst placed the shares on "Positive Catalyst Watch" into the Q1 results. | ||||
